200 related articles for article (PubMed ID: 37834202)
21. Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells.
Spina R; Filocamo G; Iaccino E; Scicchitano S; Lupia M; Chiarella E; Mega T; Bernaudo F; Pelaggi D; Mesuraca M; Pazzaglia S; Semenkow S; Bar EE; Kool M; Pfister S; Bond HM; Eberhart CG; Steinkühler C; Morrone G
Oncotarget; 2013 Aug; 4(8):1280-92. PubMed ID: 23907569
[TBL] [Abstract][Full Text] [Related]
22. Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors.
Mega T; Lupia M; Amodio N; Horton SJ; Mesuraca M; Pelaggi D; Agosti V; Grieco M; Chiarella E; Spina R; Moore MA; Schuringa JJ; Bond HM; Morrone G
Cell Cycle; 2011 Jul; 10(13):2129-39. PubMed ID: 21593590
[TBL] [Abstract][Full Text] [Related]
23. Constitutive Activation of Nrf2 in Mice Expands Enterogenesis in Small Intestine Through Negative Regulation of Math1.
Yagishita Y; McCallum ML; Kensler TW; Wakabayashi N
Cell Mol Gastroenterol Hepatol; 2021; 11(2):503-524. PubMed ID: 32896624
[TBL] [Abstract][Full Text] [Related]
24. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract][Full Text] [Related]
25. The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation.
Matsubara E; Sakai I; Yamanouchi J; Fujiwara H; Yakushijin Y; Hato T; Shigemoto K; Yasukawa M
J Biol Chem; 2009 Feb; 284(6):3480-7. PubMed ID: 19049973
[TBL] [Abstract][Full Text] [Related]
26. A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells.
Khalil HS; Langdon SP; Goltsov A; Soininen T; Harrison DJ; Bown J; Deeni YY
Oncotarget; 2016 Nov; 7(46):75874-75901. PubMed ID: 27713148
[TBL] [Abstract][Full Text] [Related]
27. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
28. Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.
Wei Y; Gong J; Thimmulappa RK; Kosmider B; Biswal S; Duh EJ
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3910-8. PubMed ID: 24062466
[TBL] [Abstract][Full Text] [Related]
29. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract][Full Text] [Related]
31. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.
Huang CC; Cheng SH; Wu CH; Li WY; Wang JS; Kung ML; Chu TH; Huang ST; Feng CT; Huang SC; Tai MH
Oncogene; 2019 Apr; 38(17):3201-3215. PubMed ID: 30626939
[TBL] [Abstract][Full Text] [Related]
32. NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.
Kim JH; Thimmulappa RK; Kumar V; Cui W; Kumar S; Kombairaju P; Zhang H; Margolick J; Matsui W; Macvittie T; Malhotra SV; Biswal S
J Clin Invest; 2014 Feb; 124(2):730-41. PubMed ID: 24463449
[TBL] [Abstract][Full Text] [Related]
33. Molecular Targeting of Notch Signaling Pathway by DAPT in Human Ovarian Cancer: Possible Anti Metastatic Effects.
Akbarzadeh M; Majidinia M; Fekri Aval S; Mahbub S; Zarghami N
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3473-3477. PubMed ID: 30583672
[TBL] [Abstract][Full Text] [Related]
34. Canonical Notch signalling is inactive in urothelial carcinoma.
Greife A; Jankowiak S; Steinbring J; Nikpour P; Niegisch G; Hoffmann MJ; Schulz WA
BMC Cancer; 2014 Aug; 14():628. PubMed ID: 25167871
[TBL] [Abstract][Full Text] [Related]
35. ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling.
Yazaki K; Matsuno Y; Yoshida K; Sherpa M; Nakajima M; Matsuyama M; Kiwamoto T; Morishima Y; Ishii Y; Hizawa N
Eur J Cell Biol; 2021; 100(7-8):151181. PubMed ID: 34763128
[TBL] [Abstract][Full Text] [Related]
36. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
Konstantinopoulos PA; Spentzos D; Fountzilas E; Francoeur N; Sanisetty S; Grammatikos AP; Hecht JL; Cannistra SA
Cancer Res; 2011 Aug; 71(15):5081-9. PubMed ID: 21676886
[TBL] [Abstract][Full Text] [Related]
37. The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB.
Garcia-Heredia JM; Lucena-Cacace A; Verdugo-Sivianes EM; Pérez M; Carnero A
Clin Cancer Res; 2017 Jul; 23(14):3871-3883. PubMed ID: 28153862
[No Abstract] [Full Text] [Related]
38. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
39. ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression.
Yang N; Wang L; Chen T; Liu R; Liu Z; Zhang L
J Cancer; 2020; 11(19):5831-5839. PubMed ID: 32913476
[TBL] [Abstract][Full Text] [Related]
40. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer.
Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
